CSA MEDICAL, INC.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 1993-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.rejuvenair.com
Clinical Trials
18
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
RejuvenAir® System Trial for COPD With Chronic Bronchitis
- Conditions
- Chronic Bronchitis
- First Posted Date
- 2019-03-28
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- CSA Medical, Inc.
- Target Recruit Count
- 210
- Registration Number
- NCT03893370
- Locations
- 🇺🇸
Honor Health, Scottsdale, Arizona, United States
🇺🇸El Camino Hospital, Mountain View, California, United States
🇺🇸University of California, Davis Medical Center, Sacramento, California, United States
Metered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
- Conditions
- COPDChronic Bronchitis
- First Posted Date
- 2019-03-27
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- CSA Medical, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT03892694
- Locations
- 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
🇬🇧The Royal Brompton Hospital, London, United Kingdom
Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients
- Conditions
- Cryotherapy EffectBronchitis, Chronic
- First Posted Date
- 2015-06-29
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- CSA Medical, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02483637
- Locations
- 🇨🇦
St. Paul's Hospital, Vancouver, British Columbia, Canada
🇳🇱University Medical Center Groningen, Groningen, Netherlands
🇬🇧Chelsea and Westminster Hosptial/Royal Brompton Hosptial, London, United Kingdom
RejuvenAir Lobectomy for Safety and Histology
- Conditions
- Lung NeoplasmsPulmonary Neoplasms
- First Posted Date
- 2015-06-26
- Last Posted Date
- 2017-05-11
- Lead Sponsor
- CSA Medical, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT02483052
- Locations
- 🇨🇦
William Osler Health System, Brampton, Ontario, Canada
RejuvenAir™ System Lobectomy Safety and Histology Study
- Conditions
- Lung CancerLung NeoplasmsAirway Obstruction
- First Posted Date
- 2014-04-08
- Last Posted Date
- 2017-05-11
- Lead Sponsor
- CSA Medical, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT02106143
- Locations
- 🇮🇪
Galway University Hosptial, Galway, Ireland
🇳🇱University Medical Center Groningen, Groningen, Netherlands
🇬🇧Royal Brompton Hospital, London, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- Next